In vitro model of normal, immortalized ovarian surface epithelial and ovarian cancer cells for chemoprevention of ovarian cancer
Molly Brewer(UConn Health), Changping Zou(University of Arizona), Robert C. Bast(The University of Texas MD Anderson Cancer Center), Jian Wang(Qilu Hospital of Shandong University), Amanda McWatters(The University of Texas MD Anderson Cancer Center), Nelly Auersperg(University of Central Florida), J. Taylor Wharton(The University of Texas MD Anderson Cancer Center), David M. Gershenson(The University of Texas MD Anderson Cancer Center)
Cited by 17
Related Papers
Reactivity of a monoclonal antibody with human ovarian carcinoma.
|Journal of Clinical Investigation|1981|1.7k
Rethinking ovarian cancer: recommendations for improving outcomes
|Nature reviews. Cancer|2011|1.5k
Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer
|Nature reviews. Cancer|2015|1.4k
National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines for Use of Tumor Markers in Testicular, Prostate, Colorectal, Breast, and Ovarian Cancers
|Clinical Chemistry|2008|1.1k
Ovarian Surface Epithelium: Biology, Endocrinology, and Pathology*
|Endocrine Reviews|2001|999